The transcriptional activating (Tat) proteins from human immunodeficiency virus and simian immunodeficiency virus are sequence-specific RNA-binding proteins. In human immunodeficiency virus Tat, a single arginine residue, flanked on each side by three to four basic amino acids, mediates specific binding to a bulge region in trans-acting responsive element (TAR) RNA. We have systematically mutated the flanking charged residues and found that, in addition to the position of the sequence-specific arginine, the particular arrangement of nonspecific electrostatic interactions is an important determinant of RNA-binding specificity and transactivation activity. These additional electrostatic contacts may help stabilize the structure of TAR RNA when bound to arginine. One critical electrostatic interaction, located two residues N-terminal to the arginine, is absent in the simian immunodeficiency virus Tat protein and accounts for the difference in promoter specificities of the human and simian immunodeficiency viral proteins.
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phosphates at a bulge. To examine the electrostatic requirements for Tat-TAR recognition, we have systematically mutated each basic amino acid in the RNA-binding domain of Tat and found that, in addition to requiring a specific position for the arginine, the precise charge distribution strongly influences activity. We have also found that the absence of one charged residue in SIV Tat accounts for previously observed differences in the transactivation specificities of the HIV and SIV Tat proteins. HIV Tat is known to efficiently transactivate the HIV and SIV promoters, whereas SIV Tat (or the closely related HIV-2 Tat) transactivates the HIV promoter with -'5-fold lower activity (12) (13) (14) (15) (16) (17) . Sequence comparisons indicate that although all three Tat proteins are closely related (18) , SIV Tat (or HIV-2 Tat) is missing one basic amino acid, located two residues N-terminal to the sequence-specific arginine, found in HIV Tat. We show that substituting serine with lysine at this position converts the specificity of SIV Tat to that of HIV Tat.
Replication of the human immunodeficiency viruses (HIVs) and the related simian immunodeficiency viruses (SIVs) depends critically on the viral regulatory protein Tat. Tat is required early in the viral life cycle to stimulate viral transcription and appears to function largely by increasing the efficiency of transcriptional elongation (for a review, see ref. 1) . To activate transcription, Tat must bind to a RNA hairpin, the trans-acting responsive element (TAR), located at the 5' end of all nascent viral transcripts (2) (3) (4) . Studies with peptides have shown that Tat binding to a 3-nt bulge in TAR is mediated by a short region ofbasic amino acids (4) (5) (6) (7) (8) and that a single arginine residue provides the only sequence-specific contact with the RNA (8). One conclusion from these studies has been that recognition must be driven largely by the precise three-dimensional structure of TAR, probably mediated through a set of hydrogen bonds between the arginine guanidinium group and acceptor groups specifically positioned on the RNA backbone and bases. The key role ofRNA structure is highlighted by the fact that the free amino acid arginine can make the same specific contacts to TAR as arginine in the context of a peptide (9) and that TAR rearranges its structure to adopt an arginine-binding conformation (10, 11) .
Although one arginine provides the sequence-specific contacts to TAR, at least three basic amino acids are required on each side of the arginine to provide electrostatic contacts and to raise the overall binding affinity (8) (9) (10) . In principle, these interactions also could enhance the specificity of arginine binding-for example, by neutralizing the unusually high density of negative charges created by positioning several LTR (nt -751 to +85) 5' to the CAT gene and was constructed by replacing the Xho I-HindIII fragment from pHIV CAT with a BanII-BanII fragment (SIV nt -751 to +29) from pSIV LTR CAT (20) . Synthetic oligonucleotides were added to create appropriate ends for cloning and to extend the 3' sequence to SIV nt +85. A second pSIV CAT (one hairpin) reporter was constructed in which the 3' end was extended only to SIV nt +53 and contains a single TAR RNA hairpin, rather than the two hairpins normally present in the LTR (see Results). HIV Tat protein was expressed using pSV2tat72 (21) , in which expression of a synthetic tat gene (encoding amino acids (23) .
MATERIALS AND METHODS

RESULTS
Charge Requirements of the RNA-Binding Domain of HIV Tat. Previous studies have shown that the RNA-binding domain of Tat (residues 49-57; RKKRRQRRR) requires a high density of positive charges for optimal RNA-binding and transactivation activity (7, 24, 25) . Sequence specificity is mediated by a single arginine residue, but surrounding charges are apparently required to raise the overall binding affinity (8) . By placing the arginine at every position within an all-lysine background, it was shown that the arginine must be located near the middle of the basic region (optimally at amino acid 52; KKKRKKKKK) (8) . Because electrostatic interactions also might influence the specificity of arginine binding and because the precise distribution of charges might provide clues about the structure and orientation of the Tat peptide-TAR complex, we constructed mutant Tat proteins containing systematic changes in the number and distribution of charges and determined their transactivation activities.
In the first set of mutants (Table 1) , we found that two charges could be removed from the C terminus of the RNAbinding domain with only a slight loss of activity (compare KKKRKKKKK with KKKRKKK). Removing any additional charge, by replacing each lysine in KKKRKKK with alanine, markedly reduced activity (Table 1) . Basic amino acids located two residues N-or C-terminal to the arginine (the i -2 or i + 2 positions) are particularly important. To confirm that these mutants accurately reflected the RNA-binding activity of Tat, gel-shift assays were done with a corresponding set of mutant peptides. Previous studies have established an excellent correlation between the activities of Tat mutants in vivo and the specific RNA-binding affinities of corresponding (Table 1) , even though it contains one additional charge. This result probably reflects the spacing requirement of the arginine (see below).
Having established that three charges are required on each side of the arginine, we next asked whether it is important for the arginine, when surrounded by three lysines on each side, to be located at a particular position within the intact Tat protein. As the set of mutants in Table 3 demonstrates, moving the arginine one amino acid closer to the N terminus does not affect activity (compare with the Gly-48 --Lys mutant, which itself has reduced activity), whereas moving the arginine farther from the N terminus results in a gradual decrease in activity. The fact that the specific arginine requires a particular location within Tat suggests that when Tat is bound to TAR, the spacing and/or orientation of the activation domain, relative to the nascent RNA, influences Tat transactivation.
To ensure that the measured differences in transactivation reflect true specific activities of the mutant Tat proteins rather than differences in protein expression level, protein stability, or nuclear localization, we measured steady-state levels and subcellular localization of various Tat mutants after transient transfection. In particular, it was possible that mutations that removed basic residues (see Tables 1 and 2) might have removed the nuclear localization signal that overlaps with the RNA-binding domain (26) (27) (28) . Immunoprecipation of 35S-labeled Tat from nuclear and cytoplasmic extracts indicated that expression levels were similar and that each Tat protein was localized predominantly to the nucleus (Fig. 1) . Nuclear localization was confirmed by immunofluorescence (data not shown).
A Difference in Charge Distribution Accounts for the Different Specificities of HIV and SIV Tat. Previous studies have shown that the specificities oftransactivation of HIV Tat and SIV Tat (or ofHIV-2 Tat, which is closely related to SIV Tat) differ (12) (13) (14) (15) (16) (17) . In particular, although HIV Tat is very active on the HIV, SIV, and HIV-2 LTRs, the SIV (or proteins are several-fold less active on the HIV LTR. (For this paper, we refer to HIV-1 simply as HIV). Because Tat transactivation depends on the Tat-TAR interaction, we asked whether the difference in specificities between HIV and SIV Tat might be related to any known TAR RNAbinding properties. By aligning the protein sequences ( Fig.  2A) , it was immediately apparent that a potentially significant difference existed between the two RNA-binding domains. In SIV Tat, there is an arginine located at position 81, equivalent to Arg-52 in HIV Tat, but there are fewer than three positively charged residues N-terminal to the arginine. In (equivalent to the critical i -2 position identified above), which, in principle, might reduce the affinity of SIV Tat for HIV TAR RNA and, thus, reduce its activity on the HIV promoter. There is also a histidine located at position 80 of SIV Tat (instead ofa lysine at position 51 ofHIV Tat), but this histidine may be positively charged (see below).
Because the previous studies used different reporter systems and Tat expression vectors, we first wished to confirm the relative activities of HIV and SIV Tat in our assay system. We constructed a set of HIV and SIV LTR CAT reporters and Tat expression plasmids with identical backgrounds (see Materials and Methods) and determined Tat activities by cotransfecting plasmids into HeLa cells and measuring CAT activity. As reported (13, 16) , SIV Tat transactivated the HIV promoter -3-fold less efficiently than HIV Tat (Fig. 2 B and C) , whereas both proteins showed similar activities on the SIV promoter ( Fig. 3 ; data not shown). We also observed that although the level of transactivation by HIV Tat was similar with both reporters, the basal level of CAT activity was 3-to 5-fold lower from pSIV CAT than from pHIV CAT. To normalize for this difference, the amount of each reporter plasmid was adjusted to match the basal activities.
To test whether the lack of a positive charge at position 79 in SIV Tat (and/or the histidine at position 80) was responsible for its reduced activity on the HIV promoter, we constructed an SIV Tat mutant in which Ser-79 was replaced with lysine and a second mutant in which both Ser-79 and His-80 were replaced with lysines. The Ser-79 --Lys substitution yielded an SIV Tat with activity indistinguishable from HIV Tat when assayed on the HIV promoter ( Fig. 2 B  and C) . The activity ofthe double mutant was identical to that of the single mutant (data not shown), suggesting that histidine at position 80 may be positively charged in vivo or, as suggested by the HIV Tat mutants described above, that this i -1 position is less critical. Thus, as predicted by the sequence comparison, the absence of a positive charge at amino acid 79 of SIV Tat reduces its activity on the HIV promoter. The activity of both mutants was the same as wild-type SIV Tat when assayed on the SIV promoter (data not shown), indicating that the mutations affected promoter specificity rather than simply increasing overall transactivation activity.
The Effect of a Second RNA Hairpin on the SIV Promoter. Although the results above seem sufficient to explain the difference in Tat specificities, it had been suggested that the existence of two tandem TAR hairpins in the SlV and HIV- . An appropriate amount of extract was assayed and quantitated, as described (7). Assays were repeated at least three times, and the reported activities have errors of <20o. Fold transactivation is the ratio of CAT activity from each concentration of Tat-expressing plasmid to cells transfected only with the reporter plasmid. might influence Tat specificity (17) . To examine this possibility, we constructed an additional pSIV CAT reporter containing only the first TAR hairpin and compared its activity with the two-hairpin reporter. Although removing the second hairpin reduced the total level of transactivation, the specificity for Tat transactivation was identical to the twohairpin reporter and did not change to the phenotype of the single TAR-containing HIV promoter (Fig. 3) . Thus, the number of TAR hairpins does not seem to determine the relative specificities of HIV and SIV Tat.
DISCUSSION
Transcriptional activation by HIV or SIV Tat requires specific binding of Tat to a TAR RNA hairpin located at the 5' end of nascent transcripts. RNA-binding specificity is mediated by a single arginine residue in HIV Tat, and similar specificity is observed with the free amino acid arginine (8) (9) (10) . Recent NMR results, combined with previous chemical modification and mutagenesis studies, suggest that the arginine guanidinium group forms a set of hydrogen bonds pSIV CAT pSIV CAT pHIV CAT (2 hairpin) (1 hairpin) FIG. 3. The second TAR RNA hairpin in the SIV LTR increases the total level of transactivation but does not affect Tat specificity. Tat-expressing plasmids (pSV2tat72, HIV Tat; pSV2SIVtat, SIV Tat) were cotransfected with pSIV CAT (10 ng), pSIV CAT (one hairpin) (10 ng), or pHIV CAT (3 ng), and activity was determined as in Fig. 2 . Tat-expressing plasmids were titrated as in all experiments, but only the 25-ng point is plotted. Similar relative activities were observed at the other plasmid concentrations.
with two phosphates located below the bulge in TAR and with a guanine base located above the bulge, and that this RNA structure is stabilized by a base triple interaction (ref. 11; Fig.  4 ). In the absence of arginine, a different RNA conformation is favored, in which the bulge nucleotides are partially stacked within one strand of a helix and the base triple does not form (ref. 11; Fig. 4) .
The importance of electrostatic interactions, as demonstrated in this paper, may relate to the conformational change in TAR seen upon arginine binding (10, 11) . In unbound TAR, the three phosphates in the bulge are relatively far apart, being essentially part of a helical conformation (Fig. 4) . Upon arginine binding, several phosphates, including those in the bulge, are brought close together to accommodate the base triple (Fig. 4) . Although the formation of specific hydrogen bonds and electrostatic interactions between arginine and RNA is apparently sufficient to stabilize the bound confor- Proc. Natl. Acad. Sci. USA 90 (1993) A mation, the unfavorable phosphate arrangement at the bulge may help keep TAR in its unbound conformation in the absence of arginine. In the context of the Tat protein or peptide, basic side chains that surround the arginine may interact with phosphates in the bulge, thus neutralizing some of the unfavorable charge and stabilizing the bound conformation. It has been observed that ethylation of the bulge phosphates enhances free arginine binding (9) but does not enhance peptide binding (unpublished results), consistent with a model in which either ethylation or interaction with basic amino acids neutralizes the phosphate charge. The data presented here suggest that while there is flexibility in positioning these "nonspecific" electrostatic interactions relative to the arginine, the optimal charge distribution is not random, and certain positions (particularly i -2 and i + 2) contribute significantly to RNA-binding specificity (Tables 1  and 2 ). The unstructured nature of the RNA-binding domain (7, 8) may enable the peptide to "conform" to the RNA shape.
The biological importance of the surrounding electrostatic interactions can be seen by comparing transactivation specificities of the HIV and SIV Tat proteins. Previous studies had shown that although HIV Tat is very active on-the HIV and SIV LTRs, the SIV protein is several-fold less active on the HIV LTR (13, 15) . We have shown that the absence of an important nonspecific electrostatic contact at the i -2 position of SIV Tat reduces its TAR-binding affinity and, thus, reduces its transactivation activity on the HIV promoter. In another study, a negatively charged glutamate residue just prior to the basic region of HIV-2 Tat was replaced by an uncharged glycine; this mutant displayed increased activity on the HIV-1 LTR (29) and is consistent with our results. The importance of the RNA-binding domain in mediating transactivation specificity is supported by an additional mutant in which the basic region of HIV Tat (residues 49-57) was replaced with the basic region of SIV Tat (residues 78-88); this mutant displayed specificity identical to that of SIV Tat, having -3-fold lower activity on the HIV promoter than HIV Tat (data not shown). Our results also show that, in addition to its position within the RNAbinding domain, the position of the arginine within intact HIV Tat is important. Similar positional requirements are seen for the SIV LTR; the activity of HIV Tat mutants containing a single arginine at positions 49-57, with lysines at the remaining eight positions, was optimal on the SIV promoter when the arginine was located at position 52 (data not shown), as seen with the HIV promoter (8) .
The question of how the SIV promoter tolerates the absence of a positive charge at position 79 of SIV Tat remains unanswered. Although the SIV and related HIV-2 promoters each contain two TAR hairpins rather than one hairpin found in the HIV promoter, the second hairpin does not seem to affect the specificities of SIV and HIV Tat (Fig. 3) . We observed that the basal activity of the SIV promoter is somewhat lower than that of the HIV promoter; the lower RNA-binding affinity of SIV Tat may be sufficient to transactivate when the rate of transcriptional initiation is lower (see ref. 1). Thus, RNA-binding may be less rate-limiting during transactivation of the SIV promoter. Understanding the differences between the HIV and SIV (or HIV-2) promoters may provide further clues to the mechanism of Tat transactivation and help to identify steps during transcription-complex assembly that determine the efficiency of elongation.
It seems reasonable that other RNA-binding proteins that contain arginine-rich regions similar to Tat (30) may interact with RNA through a combination of specific and "nonspecific" electrostatic contacts. Because such electrostatic interactions can contribute significantly to the RNA-binding affinity and perhaps to binding specificity, they are likely to be an important determinant of in vivo activity, as for Tat.
